Abstract

Trichosporon asahii is a pathogenic fungus that causes deep mycosis in patients with neutropenia. Establishing an experimental animal model for quantitatively evaluating pathogenicity and developing a genetic recombination technology will help to elucidate the infection mechanism of T. asahii and promote the development of antifungal drugs. Here we established a silkworm infection model with a transgenic T. asahii strain expressing eGFP. Injecting T. asahii into silkworms eventually killed the silkworms. Moreover, the administration of antifungal agents, such as amphotericin B, fluconazole, and voriconazole, prolonged the survival time of silkworms infected with T. asahii. A transgenic T. asahii strain expressing eGFP was obtained using a gene recombination method with Agrobacterium tumefaciens. The T. asahii strain expressing eGFP showed hyphal formation in the silkworm hemolymph. Both hyphal growth and the inhibition of hyphal growth by the administration of antifungal agents were quantitatively estimated by monitoring fluorescence. Our findings suggest that a silkworm infection model using T. asahii expressing eGFP is useful for evaluating both the pathogenicity of T. asahii and the efficacy of antifungal drugs.

Highlights

  • Trichosporon asahii is a pathogenic fungus that causes deep mycosis in patients with neutropenia

  • Whereas the mortality rate of deep mycosis caused by Candida albicans is approximately 40%, that caused by T. asahii is approximately 80%, and the prognosis is ­poor[11]

  • The ­LD50 value of the T. asahii JCM2466 strain determined in this study is lower than that of the C. neoformans H99 strain, indicating that the pathogenicity of T. asahii JCM2466 strain is higher than that of the C. neoformans H99 strain under these experimental conditions

Read more

Summary

Introduction

Trichosporon asahii is a pathogenic fungus that causes deep mycosis in patients with neutropenia. We previously established a silkworm infection model using transgenic dermatophytes expressing eGFP, and developed a method for quantifying hyphal formation by fluorescence ­imaging[43]. The therapeutic effects of antifungal drugs can be evaluated using a silkworm infection model with the transgenic T. asahii strain expressing eGFP. Evaluation of the therapeutic effects of antifungal drugs using the silkworm infection model.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call